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ABSTRACT Fast axonal transport is characterized by the
bidirectional, microtubule-based movement of membranous
organelles. Cytoplasmic dynein is necessary but not sufficient
for retrograde transport directed from the synapse to the cell
body. Dynactin is a heteromultimeric protein complex, en-
riched in neurons, that binds to both microtubules and
cytoplasmic dynein. To determine whether dynactin is re-
quired for retrograde axonal transport, we examined the
effects of anti-dynactin antibodies on organelle transport in
extruded axoplasm. Treatment of axoplasm with antibodies to
the p150Glued subunit of dynactin resulted in a significant
decrease in the velocity of microtubule-based organelle trans-
port, with many organelles bound along microtubules. We
examined the molecular mechanism of the observed inhibition
of motility, and we demonstrated that antibodies to p150Glued
disrupted the binding of cytoplasmic dynein to dynactin and
also inhibited the association of cytoplasmic dynein with
organelles. In contrast, the anti-p150Glued antibodies had no
effect on the binding of dynactin to microtubules nor on
cytoplasmic dynein-driven microtubule gliding. These results
indicate that the interaction between cytoplasmic dynein and
the dynactin complex is required for the axonal transport of
membrane-bound vesicles and support the hypothesis that
dynactin may function as a link between the organelle, the
microtubule, and cytoplasmic dynein during vesicle transport.
Neurons possess a striking asymmetric morphology in which
elongated axonal processes extend from the cell body. The
growth and maintenance of the axon, as well as the movement
of materials between the cell body and the distal tip of the
axon, rely on the mechanism of axonal transport. The fast
bidirectional transport of organelles along the polarized mi-
crotubule array of the axon has been well characterized (1–8).
Many microtubule-based motors have been identified in neu-
rons, including members of the kinesin superfamily that are
implicated in anterograde transport (4, 5) and cytoplasmic
dynein, which is required for retrograde transport (6–8).
The molecular mechanisms by which these motors are
specified for particular types of organelle cargo, as well as the
regulation of the interactions between motor proteins, or-
ganelles, and microtubules, are largely unknown. A soluble
accessory factor, dynactin, was originally isolated via its co-
purification with cytoplasmic dynein and is one candidate for
the activation of cytoplasmic dynein-based organelle motility
(reviewed in ref. 9). Dynactin consists of at least seven
different polypeptides that cosediment at 20 S (10, 11). These
include p150Glued; the actin-related protein centractin (Arp-1);
the a and b subunits of capping protein (CapZ); dynamitin; as
well as uncharacterized polypeptides with molecular masses of
62 and 24 kDa (10–17). The largest dynactin polypeptide,
p150Glued, is capable of multiple, specific binding interactions.
p150Glued binds to the 74-kDa intermediate chain of cytoplas-
mic dynein via a domain in the central region of the molecule
(18, 19) and also binds directly to microtubules via an N-
terminal microtubule-binding motif (20).
Genetic studies have shown that both cytoplasmic dynein
and dynactin participate in mitotic spindle orientation and
nuclear migration (reviewed in ref. 9). In addition, results from
an in vitro vesicle motility assay implicated dynactin in the
cytoplasmic dynein-based transport of membranous vesicles
(13). In this report, we examined the role of dynactin in fast
axonal transport in axoplasm extruded from the giant axon of
the squid, a system in which the requirement for cytoplasmic
dynein as a retrograde motor has previously been established
(6, 7). We report that anti-dynactin antibodies that block the
dynein–dynactin interaction inhibit organelle transport along
microtubules.
MATERIALS AND METHODS
Antibody Production and Immunochemistry. Polyclonal
rabbit antibodies UP235 and UP236 were raised against pu-
rified recombinant polypeptides corresponding to residues
39–1325 and 150–899 of rat p150Glued, respectively (17).
Polyclonal rabbit antibodies UP384 and UP385 were raised to
purified recombinant polypeptides corresponding to residues
216–376 and 3–376 of human centractin, respectively (11).
These antibodies were affinity purified as described (17). Fab
fragments were prepared by papain digestion and purified by
protein-A agarose affinity chromatography (21). In control
experiments, anti-p150Glued antibodies UP235 and UP236 were
blocked by incubation overnight with a 50-fold molar excess of
immunogen polypeptide, followed by protein-A agarose affin-
ity purification. Western blots were performed as previously
described (22).
Isolation and Characterization of Dynactin from Squid.
Squid optic lobe cytosol was generated by homogenization of
frozen optic lobes (generously provided by R. Sloboda, Dart-
mouth College, Hanover, NH) in one volume of either PHEM
(50 mM Na Pipesy50 mM Hepesy1 mM EDTAy2 mM MgCl2,
pH 7.0) or axoplasmic motility buffer (400 mM potassium
aspartatey20 mM Hepesy5 mM MgCl2z6H2Oy0.5 mM CaCl2y
1.5 mM EGTAy2 mM ATPy30 mM glyciney40 mM betainey74
mM tauriney0.5 mM DTT, pH 7.2) with protease inhibitors (1
mM PMSF, 10 mgyml leupeptin, 10 mgyml N-tosyl L-arginine
methylester, and 1 mgyml pepstatin A) followed by sequential
centrifugation at 39,000 3 g and 150,000 3 g. The 0.4 M NaCl
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extract of bovine brain microtubules was prepared as described
(12).
The sedimentation coefficient of squid dynactin was deter-
mined by sucrose density gradient sedimentation of optic lobe
cytosol as previously described (22). Dynactin was immuno-
precipitated from optic lobe cytosol prepared in RIPA buffer
without SDS (50 mM TriszHCl, pH 7.5y150 mM NaCly1%
Nonidet P-40y0.5% deoxycholate) using either UP235 or
UP236 as described (22).
Antibody Inhibition of Organelle Motility in Extruded
Axoplasm. Squid were obtained fresh daily from the Depart-
ment of Marine Resources (Woods Hole, MA). Giant axons
were dissected as previously described (1) and cut in half. One
half of the axoplasm was extruded into motility buffer with 0.8
mgyml of affinity-purified antibodies and the other half was
extruded into a control solution. Samples were observed within
1 hr after extrusion by video-enhanced contrast differential
interference contrast (VEC-DIC) microscopy (23) on the
Zeiss Axiophot video microscope system as previously de-
scribed (24).
Motile activity (number of organelles movingyfield per sec)
was analyzed from videotapes by counting the total number of
moving organelles in four areas (5 3 5 mm) over 15-sec
intervals. Motion analysis of organelle movement along indi-
vidual microtubules was performed as described using the
software packages PARTI-MOVI or SPSS (23, 25).
Affinity Chromatography and Microtubule Cosedimenta-
tion Assays. p150Glued affinity columns were prepared as
described (18) using a 200-ml bed volume. The columns were
preadsorbed with either preimmune serum or anti-p150Glued
(UP235) serum and washed with 20 column volumes of PBS.
The columns were further washed with 5-column volumes of
1 M LiCly150 mM NaCly10 mM TriszHCly0.5% Nonidet P-40,
pH 8.0. The columns were equilibrated in axoplasmic motility
buffer and loaded with 600 ml squid optic lobe cytosol pre-
pared in motility buffer, then washed with 20 vol of motility
buffer, and finally eluted with motility buffer with 500 mM
NaCl. The final washes and the eluates were TCA-precipitated
and analyzed by SDSyPAGE, followed by Western blotting
using antibodies to heavy and intermediate chains of cytoplas-
mic dynein [generously provided by Drs. David Asai (Purdue
University, West Lafayette, IN) and Walter Steffen (Vienna
University, Austria)].
To assay the effects of antibodies on the interaction of
dynactin with microtubules, cytosol was incubated with 1
mgyml affinity-purified antibody for 45 min at room temper-
ature. Taxol (40 mM, National Cancer Institute, Bethesda,
MD) was added, and the incubation was continued for 30 min
at 37°C. Taxol-stabilized microtubules (0.25 mgyml) were
added, and incubation continued for a final 30 min at 37°C.
Alternatively, antibodies were added after microtubule poly-
merization. Microtubules and associated proteins were then
isolated by microcentrifugation and washed once, and the
supernatant and pellet fractions were analyzed by immunoblot.
Organelle Isolation and Analysis. Axoplasmic organelles for
immunoblot analysis were isolated by flotation on a sucrose
step gradient as previously described (26, 27). Organelles were
prepared from squid optic lobes by modification of the pro-
cedure of Niclas et al. (28). Briefly, optic lobes were homog-
enized in 1 vol of motility buffer with protease inhibitors; the
homogenate was centrifuged for 30 min at 4°C at 25,000 3 g.
The resulting supernatant was subjected to ultracentrifugation
at 80,000 3 g to obtain a pellet fraction that was enriched in
organelles and a high-speed supernatant (cytosol). The pellet
fraction was either resuspended in motility buffer alone or in
motility buffer with 0.8 mgyml of anti-p150Glued antibody
UP235. The organelle fractions were incubated at room tem-
perature for 45 min followed by 15 min at 37°C. The organelle
and cytosol fractions were then brought to a final sucrose
concentration of 2 M and layered underneath steps of 1.5 M
and 0.6 M sucrose in motility buffer. The gradients were
centrifuged at 200,000 3 g for 2 hr at 4°C. Samples were
collected from the 1.5 My0.6 M interface, the 1.5 M step, and
the 2 M step from each gradient and were analyzed by
SDSyPAGE and Western blotting. Results were analyzed
using a UMAX PowerLook II scanner and NIH IMAGE soft-
ware.
In Vitro Microtubule Gliding Assays. 20S cytoplasmic dy-
neinydynactin and 9S kinesin fractions were isolated from
optic lobe (16). Cytoplasmic dyneinydynactin with either
('200 mgyml protein) and kinesin ('100 mgyml protein) were
incubated 40 min at 20°C with either 1 mgyml affinity-purified
antibody or 1% BSA in PEM (80 mM Pipesy2 mM MgCl2y1
mM EGTA, pH 6.9) and introduced into a slideycoverslip flow
chamber coated with 10 mgyml casein in PEM, and then rinsed
with PEMT (PEM containing 10 mm Taxol and 0.1% 2-
mercaptoethanol). Taxol-stabilized microtubules in PEMT
with 10 mM ATP were introduced into the chamber, and
microtubule gliding was observed by VEC-DIC as described
(29). Analysis was performed using RTM custom software (30).
The velocities of three to five microtubules were determined
per 27 mm 3 27 mm microscopic field examined, with at least
three fields examined per preparation.
RESULTS
Antibody Specificity and Characterization of the Squid
Dynactin Complex. Polyclonal antibodies raised against mam-
malian forms of p150Glued and centractin were used to inves-
tigate the role of dynactin in axonal transport in the well-
characterized extruded squid axoplasm system. Two p150Glued
antibodies, UP235 and UP236, raised against overlapping
regions of the protein expressed from a rat cDNA encoding
p150Glued were found to react specifically with a polypeptide of
160 kDa in squid axoplasm and optic lobe cytosol (Fig. 1A).
Antibody UP235 also demonstrated minor reactivity with a
polypeptide of '80 kDa. However, blocking the antibody with
excess immunogen completely inhibited the reactivity with the
160-kDa band while not affecting the reactivity with the
80-kDa polypeptide (data not shown). A polyclonal antibody
raised against human centractin, UP384, specifically recog-
nized a 45-kDa polypeptide in squid axoplasm (Fig. 1 A),
whereas a second anti-centractin antibody, UP385, did not
react with the squid polypeptide and therefore was used as a
control in the inhibition experiments described below.
Both the 160- and 45-kDa immunoreactive squid proteins
cosedimented from whole optic lobe cytosol at 20 S on a
5–25% linear sucrose density, indicating that they are members
of a cytosolic macromolecular complex (Fig. 1B). Both anti-
p150Glued antibodies (UP236, Fig. 1C, or UP235, data not
shown) coimmunoprecipitated five major polypeptides from
optic lobe cytosol (168, 160, 82, 50, and 45 kDa) (Fig. 1C);
these polypeptides are similar in size to those coprecipitated
with anti-p150Glued antibodies from rat brain cytosol (150, 135,
62, 50, and 45 kDa; ref. 17). Immunoblot analysis of the squid
immunoprecipitate showed that both the 168- and 160-kDa
polypeptides reacted with anti-p150Glued antibodies, whereas
the 45-kDa protein was recognized by anti-centractin antibody
UP384. The 168-kDa polypeptide may represent a low-
abundance isoform of the 160-kDa protein that is not detected
in whole squid cytosol but that is concentrated in the immu-
noprecipitated sample. Isoform diversity due to alternative
splicing of a single p150Glued gene has been characterized in
other species (17). These results demonstrate the specificity of
these antibodies for the squid dynactin complex.
Anti-p150Glued Antibodies Inhibit Microtubule-Based Fast
Axonal Transport. To investigate the role of the dynactin
complex in fast transport in the squid axon, we treated
extruded axoplasm with antibodies to p150Glued and centractin.
Freshly dissected axons were divided in half; one half was
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extruded into motility buffer containing 0.8 mgyml affinity-
purified antibody while the other half was used as an internal
control. Following extrusion into buffer alone, organelles
moved bidirectionally and continuously at '2 mmysec in both
the central (bulk) regions of the axoplasm, where the native
structure and polarity of the axon is retained (Table 1), and
along individual microtubules in dissociated regions of axo-
plasm (Fig. 2), consistent with previous observations (1–3).
In contrast, after a 60-min incubation of axoplasm with 0.8
mgyml of affinity-purified anti-p150Glued antibody we ob-
served a significant reduction in organelle velocity in bulk
axoplasm as compared with control values (UP235 induced a
70% inhibition compared with controls; UP236 induced a 50%
inhibition) (Table 1). Both of the anti-p150Glued antibodies
caused the bulk axoplasm to appear ‘‘frozen,’’ with organelles
clearly stopped along microtubules and undergoing no Brown-
ian motion (Table 1).
FIG. 1. Characterization of the squid dynactin complex. (A) SDSy
PAGE and immunoblot analysis of squid optic lobe cytosol (first lane),
axoplasm (second lane), and a bovine brain fraction highly enriched in
dynactin (third lane), stained for total protein, and probed with the
anti-p150Glued antibodies UP235 and UP236 and with anti-centractin
antibodies UP384 and UP385. (B) Squid optic lobe cytosol was
sedimented on a 5–25% linear sucrose gradient, and gradient fractions
were analyzed by SDSyPAGE and immunoblot with antibodies to
p150Glued (Upper) and to centractin (Lower). The arrow indicates 20 S.
(C) Anti-p150Glued antibody UP236 was used to immunoprecipitate
dynactin from squid optic lobe cytosol. The immunoprecipitate was
resolved by 8% SDSyPAGE and stained for total protein with
Coomassie blue (lane 1). The band at 55 kDa is the IgG heavy chain,
and the band at 66 kDa is BSA. Immunoblot analysis of the immu-
noprecipitate with anti-p150Glued antibody UP235 (lane 2) and anti-
centractin antibody UP384 (lane 3). (D) Axoplasmic organelles were
resolved by SDSyPAGE on a 10% gel and stained for total protein
(lane 1). Immunoblotting was performed with anti-p150Glued antibody
UP235 (lane 2) and anti-centractin antibody UP384 (lane 3).
FIG. 2. Effects of antibodies on organelle motility along individual
microtubules. VEC-DIC micrographs of axoplasm taken at 1S inter-
vals following a '45-min incubation in 0.8 mgyml anti-p150Glued
antibody UP-235 (A) or after '45 min in motility buffer (B). (A)
Organelle at white carat is moving at 0.0 mmysec; organelle at white
star is moving at 0.3 mmysec; organelle at white dot is moving at 0.3
mmysec in the opposite direction along the same microtubule. (B)
Organelle at black star moving at 2.0 mmysec. Bar 5 10 mm. (C)
Average velocities of organelle motility along individual microtubules
were determined at 20 and 40 min. Affinity-purified antibodies to
p150Glued (UP235 or UP236) or control antibodies (UP385) were at 0.8
mgyml; Fab fragments of affinity-purified anti-p150Glued antibodies
[UP235 (Fab) or UP236 (Fab)] were at 0.5 mgyml. Average velocities
for organelle motility [presented as mean (in mmysec) 1y2 SEM] are
as follows: buffer, 20 min: 2.3 6 0.2, n 5 40, 40 min: 2.0 6 0.2, n 5
36; UP385, 20 min: 2.2 6 0.2, n 5 20, 40 min: 1.7 6 0.3, n 5 22; UP236,
20 min: 1.2 6 0.3, n 5 10, 40 min: 1.0 6 0.2, n 5 10, UP235, 20 min:
0.9 6 0.2, n 5 36, 40 min: 0.5 6 0.1, n 5 18, UP236 Fab fragments,
40 min: 1.0 6 0.5, n 5 13, UP235 Fab fragments, 40 min: 0.3 6 0.1,
n 5 6.
Table 1. Effect of antibodies on organelle motility in bulk regions





Buffer 2.0 6 0.4, n 5 28 1
Anti-centractin
UP-385 2.1 6 0.4, n 5 21 1
Anti-p150Glued
UP-235 0.6 6 0.4, n 5 5 2
UP-235 (Fab) 0.4 6 0.1, n 5 4 2
UP-236 1.0 6 0.2, n 5 10 2y1
UP-236 (Fab) 0.9 6 0.4, n 5 11 2y1
The central axoplasm was examined by VEC-DIC 60 min after
extrusion into either motility buffer alone, buffer containing 0.8
mgyml of affinity-purified antibody, or 0.5 mgyml affinity-purified
Fab fragments. 1, .50 organelles moving per microscopic field;
2y1, ,10 organelles moving per microscopic field; 2, ,1 organelle
moving per microscopic field.
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Examination of motility in the peripheral regions of the
extruded axoplasm demonstrated a significant reduction in
organelle velocity along individual microtubules after a 40-min
incubation with antibody (75% inhibition with UP235; 50%
inhibition with UP236; Fig. 2). Individual organelles that were
bound to microtubules either continued to move very slowly or
were stopped completely, remaining bound to microtubules,
often at one end, and undergoing neither Brownian movement
nor one-dimensional diffusion along the microtubule lattice
(Fig. 2 A). There was no obvious increase or decrease in the
number of organelles associated with microtubules.
In contrast to the inhibitory effects of the anti-p150Glued
antibodies, treatment with 0.8 mgyml of the immunoreactive
UP384 anti-centractin antibody had little effect on the velocity
of organelle motility in either the bulk or peripheral axoplasm
(bulk, 20% reduction after 60 min, Table 1; peripheral, 35%
reduction after 40 min, Fig. 2).
As controls for the specificity of inhibition by anti-p150Glued
antibodies, extruded axoplasm was treated either with 1 mgyml
of the non-cross-reactive anti-centractin antibody or with
immunogen-blocked anti-p150Glued antibodies (either UP235
or UP236). Neither of the control treatments had any signif-
icant effects on organelle motility either in bulk or in disso-
ciated axoplasm (Table 1, Fig. 2, and data not shown). To
investigate whether the inhibition of motility was due to the
cross-linking of dynactin complexes by bivalent anti-p150Glued
antibody molecules, Fab fragments were prepared and tested
for their effect on organelle transport in the axoplasm. Fab
fragments (0.5 mgyml) of either UP235 or UP236 had a similar
inhibitory effect on organelle motility as that observed for
intact antibodies (Table 1 and Fig. 2).
Anti-Dynactin Antibodies Do Not Inhibit Dynein Motor
Activity. In the experiments performed in extruded axoplasm
described above, we noted that free microtubules continued to
undergo gliding movements along the coverslip surface in the
presence of the antibodies that inhibited organelle transport.
This observation supports previous results indicating that
dynactin is not required for the generation of sliding force by
cytoplasmic dynein (13). To examine the effects of the anti-
p150Glued antibodies on force production, sucrose gradient-
purified fractions of optic lobe cytoplasmic dynein and dyn-
actin or kinesin were preincubated with 1 mgyml of the
anti-p150Glued antibody UP235, and rates of microtubule glid-
ing were assayed by VEC-DIC. No significant differences were
observed from control measurements performed in the ab-
sence of antibody (dyneinydynactin alone, 0.40 6 0.04 mmysec;
dyneinydynactin with UP235, 0.41 6 0.11 mmysec; kinesin
alone, 0.15 6 0.21 mmysec; kinesin with UP235, 0.11 6 0.09
mmysec).
Anti-p150Glued Antibodies Block the Binding of Cytoplasmic
Dynein to Dynactin. p150Glued is a multifunctional protein that
is capable of binding both to cytoplasmic dynein (18, 19) and
to microtubules (20). Thus, we investigated whether antibodies
to p150Glued inhibited organelle transport in axoplasm by
specifically disrupting either of these interactions.
We used an affinity column binding assay (18) to assess the
effects of anti-p150Glued antibodies on the interaction between
dynein and dynactin. First, we demonstrated that a bacterially
expressed fragment of rat p150Glued covalently bound to a
Sepharose matrix was capable of specifically retaining intact
cytoplasmic dynein holoenzyme from squid optic lobe cytosol.
Analysis of the high-ionic-strength column eluate by SDSy
PAGE and immunoblotting revealed that both the heavy and
intermediate chains of cytoplasmic dynein were retained by the
affinity column. To determine the effect of anti-p150Glued
antibodies on the p150Glued-cytoplasmic dynein interaction,
columns were preabsorbed either with antibodies to p150Glued
or with nonspecific rabbit antisera. Optic lobe cytosol was
loaded onto each column. The columns were washed exten-
sively in motility buffer and then eluted with motility buffer
containing an additional 0.5 M NaCl. Analysis of the eluates
by immunoblotting revealed that no dynein was retained by the
UP235-blocked column, whereas blocking with serum (Fig. 3)
or BSA (not shown) had no effect on the retention of dynein
by the affinity matrix. In parallel experiments, antiserum
UP236 was also found to inhibit the binding of squid dynein to
the affinity matrix, although the inhibition of binding was less
complete (data not shown).
We then tested the effect of the anti-p150Glued antibodies on
the microtubule-binding function of the dynactin complex.
Squid optic lobe cytosol was incubated with 1 mgyml of either
of the anti-p150Glued antibodies, UP235 or UP236, for 45 min
either before or after induction of microtubule polymerization
in the cytosol by the addition of Taxol. Microtubules and
associated proteins were isolated by sedimentation, and the
resulting supernatant and pellet fractions were analyzed by
FIG. 3. Effects of anti-p150Glued antibodies on the dynein–dynactin
interaction. Optic lobe cytosol was loaded onto p150Glued affinity
columns that were preadsorbed with either preimmune serum or
UP235 serum. The columns were eluted with 0.5 M NaCl in motility
buffer. The resulting load, f lowthrough, wash, and eluate fractions
were analyzed by SDSyPAGE stained for total protein with Coomassie
blue (A) and by immunoblotting (B) using antibodies to the dynein
heavy chain (DHC, a generous gift of David Asai) or the dynein
intermediate chain (DIC, a generous gift of Walter Steffen).
FIG. 4. Effects of anti-p150Glued antibodies on the microtubule–
dynactin interaction. Optic lobe cytosol was incubated for 45 min in the
absence (control lanes) or in the presence of 1 mgyml of the affinity-
purified anti-p150Glued antibody UP235 or UP236. Microtubules were
then assembled in the cytosol and isolated by centrifugation. The
postmicrotubule supernatants (S) and microtubule pellets (P) were
then analyzed by 8% SDSyPAGE and Coomassie blue staining for
total protein (A) followed by immunoblotting with an antibody to
p150Glued (B). Molecular mass in kDa is indicated on the left.
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immunoblotting (Fig. 4). Both in the presence and absence of
antibodies, cytosolic p150Glued was found to cosediment ex-
clusively with microtubules in the pellet.
Anti-p150Glued Antibodies Inhibit the Association of Cyto-
plasmic Dynein with Organelles. Both cytoplasmic dynein and
dynactin copurify with axoplasmic vesicles (Fig. 1D). To test
the effects of the anti-dynactin antibodies on the association of
cytoplasmic dynein with membranous organelles, we isolated
a corresponding organelle fraction from squid optic lobe and
then incubated this fraction at 37°C in the absence or in the
presence of the affinity-purified anti-p150Glued antibody
UP235. Organelles were further purified by flotation on a
sucrose step gradient to separate the membrane fractions from
either soluble or particulate dynein. Parallel fractionation of
squid cytosol revealed that dynein was not found at the 1.5
My0.6 M interface in the absence of a vesicular association
(Fig. 5).
Comparisons of vesicle fractions isolated following incuba-
tion either in the absence or in the presence of the anti-
p150Glued antibody revealed no significant change in the
amount of dynactin, kinesin, tubulin, or actin associated with
membranes after normalization to account for differences in
total protein loaded per lane. However, the anti-dynactin
antibody was observed to induce nearly complete dissociation
of cytoplasmic dynein from the membrane fraction (Fig. 5).
DISCUSSION
Dynactin Is Required for Fast Axonal Transport. We have
observed that two different polyclonal antibodies to p150Glued
specifically inhibit the microtubule-based motility of or-
ganelles in squid axoplasm, indicating that the function of
dynactin is essential to fast transport in neurons. Previous
studies have shown that cytoplasmic dynein is involved in the
retrograde transport of axonal organelles (6–8) and that
cytoplasmic dynein-based vesicle transport requires cytosolic
factors other than the purified motor protein (13). In this
study, we have shown that cytoplasmic dynein requires the
function of the dynactin complex to engage in axonal transport.
Anti-p150Glued antibodies were observed to inhibit the bi-
directional transport of organelles along microtubules. Previ-
ous studies on the inhibition of axonal transport using anti-
kinesin antibodies have also noted a bidirectional inhibition
(31), suggesting that the anterograde and retrograde organelle
motors are closely linked either physically due to colocalization
(8) or through a common regulatory mechanism. Although it
has been suggested that kinesin and cytoplasmic dynein may
share a common organelle-bound receptor (32), the data
reported here do not specifically support this hypothesis.
Instead, we suggest that the rigor-like binding of organelles to
the microtubule that was induced by the anti-dynactin anti-
bodies may have physically obstructed kinesin-mediated trans-
port.
The Mechanism of Dynactin-Mediated, Cytoplasmic Dy-
nein-Driven Motility. The observed effect of anti-p150Glued
antibodies on the microtubule-based motility of organelles in
axoplasm, together with the results of our in vitro assays,
provide insight into the function of dynactin at the molecular
level. Because the anti-p150Glued antibodies that were observed
to inhibit organelle transport in axoplasm were also shown to
disrupt the binding interaction between cytoplasmic dynein
and dynactin and to disrupt the ability of dynein to bind to
membranous organelles, these results suggest that the ob-
served inhibition in vesicle transport was due to the inability of
cytoplasmic dynein to be recruited to organelles by the dyn-
actin complex. Because the p150Glued polypeptide is not likely
to be directly involved in anchoring dynactin to membranes
(discussed below), it is not surprising that anti-p150Glued
antibodies did not perturb the association of dynactin with
vesicles. Instead, due to a microtubule-binding motif at the
amino terminus of p150Glued (20), dynactin may link organelles
to the microtubule independent of any association with cyto-
plasmic dynein. This model is consistent with our observation
that antibody disruption of the dynein–dynactin interaction
resulted in the rigor-like binding of vesicles along the micro-
tubules of the dissociated axoplasm.
Although a direct interaction between cytoplasmic dynein
and phospholipids has previously been observed (33), the
physiological role of this interaction has not yet been deter-
mined. Instead, our observation that an antibody to dynactin
effectively blocks the binding of dynein to membranes suggests
that dynactin is required to mediate the dynein–vesicle inter-
action. We have recently demonstrated a direct interaction
between dynactin and spectrin, mediated by the actin-like
filament formed by centractin at the base of the dynactin
complex (11). This observation suggests that the centractin
filament in dynactin may act as a structural element linking
dynein to a membrane-bound spectrin cytoskeleton on the
organelle surface.
Our data thus support a model in which the dynactin
complex acts as the hub in the formation of a supramolecular
motile complex that: (i) links an organelle to a microtubule via
its association with spectrin, (ii) recruits cytoplasmic dynein to
FIG. 5. Effects of anti-p150Glued antibodies on the dynein–
organelle interaction. A membrane-enriched fraction from squid was
divided in half and either resuspended in motility buffer alone (M 1
buffer) or in buffer with the anti-p150Glued antibody UP235 at 0.8
mgyml final concentration (M 1 UP235). Squid cytosol was used as a
control for these experiments. The samples were fractionated on step
gradients, and samples from the 1.5y0.6-M interface (vesicular) and
the 1.5- and 2-M (soluble) fractions were analyzed by SDSyPAGE
(stained with Coomassie blue for total protein, A) and by immunoblot
(B) with antibodies to cytoplasmic dynein, dynactin, kinesin, tubulin,
and actin. (Anti-dynein intermediate chain antibody was provided by
Walter Steffen, anti-kinesin antibody was provided by B. Schnapp,
anti-tubulin antibody was from Sigma, and anti-actin antibody was
from Boehringer Mannheim.) The gels and blots were analyzed by
densitometry; when the results are normalized for equal loading per
lane, there was no significant change detected in the amount of
dynactin or kinesin associated with membranes, whereas the reduction
in the amount of dynein associated with membranes was found to be
significant.
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the organelle to initiate transport, and (iii) is required during
active dynein-based organelle transport. Cytoplasmic dynein
may be recruited to the organelle due to its binding affinity for
dynactin. Then, during active organelle transport dynactin may
play a tethering role, preventing diffusion of the organelle
away from the microtubule during the portion of the ATPase
cycle when both heads of dynein may be dissociated from the
microtubule, as we have suggested previously (20). Alterna-
tively, dynactin may be required to regulate or ‘‘activate’’
dynein in some other fashion, which remains to be determined.
However, the data described here clearly establish a critical
role for the dynein intermediate chain in linking cytoplasmic
dynein to its cargo. A similar observation recently has been
made in the study of membrane extension along microtubules
in Xenopus extracts by Steffen et al. (34).
The Dynein–Dynactin Interaction in Other Cellular Pro-
cesses. The results of our study provide direct evidence that
dynactin is required for the microtubule-based motility of
membranous organelles in neurons. Recent evidence suggests
that the interaction between dynein and dynactin is also
required for nuclear migration and for spindle orientation and
assembly (9, 16, 35). Our results may thus provide insight into
a conserved mechanism for cytoplasmic dynein-based motility
as well as into the fundamental neuronal process of fast axonal
transport at the molecular level.
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